Abbott today announced the initiation of MOBILITY, a clinical trial studying the safety and efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in patients with iliac artery disease.
Cardio
Clinical Trial Findings Show Significant Benefits With CVRx® Rheos® System
CVRx announced that longer-term data from early Rheos clinical studies show significant reductions in hypertension and improvements in heart structure and function.
Sorin Group And Orange Business Services To Develop Remote Monitoring Solution For Cardiac Patients
Sorin Group and Orange Business Services today announced an agreement to develop and service a remote monitoring solution for patients implanted with cardiac rhythm management devices.
Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System
Medtronic, Inc. today began the international launch of the Driver Sprint RX Coronary Stent System, which received the CE Mark in February 2009 and is planned to be commercially available in more than 100 countries worldwide.
Gore Receives FDA Approval For Larger Diameter, Small Profile AAA Endoprosthesis
W. L. Gore & Associates announced that it has received approval from the US Food and Drug Administration to market a 31 mm diameter version of the GORE EXCLUDER® AAA Endoprosthesis.
Trial Shows Important Clinical Benefit Of MitraClip® Therapy In High Risk Patients
Percutaneous mitral valve repair using the MitraClip® system in high-risk surgical patients with improves patient clinical status according to data from the registry arm of the EVEREST II study.
Thrombus Aspiration With Medtronic’s Export Catheter May Improve Outcomes For Heart Attack Patients
Removing thrombus from coronary arteries with the Export Aspiration Catheter from Medtronic, Inc., before implanting a stent in patients suffering a specific kind of heart attack, “results in excellent clinical outcomes,” at one year, according to new data released today at the American College of Cardiology meeting.
Medtronic’s Endeavor Stent Shows Consistent And Sustained Safety And Effectiveness Benefits At Two Years
New data released at the 2009 American College of Cardiology meeting demonstrated exceptional long-term safety and effectiveness results for the Endeavor drug-eluting coronary stent from Medtronic, Inc.
St. Jude Medical and GE Healthcare Announce Worldwide Market Launch of Wireless Integrated FFR Solution
St. Jude Medical, Inc. and GE Healthcare today announced the worldwide commercial launch of the first fully integrated wireless solution for the measurement of Fractional Flow Reserve (FFR).
Covidien Receives FDA Clearance For New Pulse Oximeter With OxiMax SPD™ Alert
Covidien announced today that the United States Food and Drug Administration has issued a 510(k)marketing clearance for the Nellcor™ OxiMax™ N-600x™ pulse oximeter with OxiMax SPD™ alert.
NovaLign nabs FDA approval for bone fixation system
NovaLign Orthopedics Inc. can now market its first product, a bone fixation system, after it received clearance from the Food and Drug Administration.
Ardian Completes $47 Million Financing Led by Medtronic to Develop Hypertension Treatment
Ardian, Inc., developer of a breakthrough catheter-based medical device to treat hypertension, announced today that Medtronic, Inc., one of the world’s leading medical technology companies, has led a $47 million financing of the company.
CardiacAssist Introduces Longer Cannula Set for Its TandemHeart® System
CardiacAssist Inc. announced today that it has introduced a longer cannula set to cardiologists and cardiac surgeons to be used with its TandemHeart® cardiac-assist device: TandemHeart Transseptal Cannula Set—Enhanced Flow 72 (THTC-EF 72).
Covidien Receives FDA Clearance for the Nellcor™ OxiMax™ N-600x™ Pulse Oximeter with OxiMax SPD™ Alert
Covidien, a leading global provider of healthcare products, today announced that the United States Food and Drug Administration has issued a 510(k)marketing clearance for the Nellcor™ OxiMax™ N-600x™ pulse oximeter with OxiMax SPD™ alert for adults.
XTENT Receives CE Mark Approval for CUSTOM NX ® Drug-Eluting Stent System
XTENT, Inc. today announced that it has received CE Mark approval for its CUSTOM NX drug-eluting stent (DES) System.
Boston Scientific Launches New Coronary Imaging Catheter
Boston Scientific Corporation today announced the launch of its iCross™ Coronary Imaging Catheter, a product designed to improve the deliverability of the Company’s market-leading intravascular ultrasound (IVUS) technology, the iLab® Ultrasound Imaging System.